ArticleJornal brasileiro de nefrologia

Rituximab in primary podocytopathies: efficacy and safety in a retrospective cohort.

Gabriel Teixeira Montezuma Sales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.